Filing Details
- Accession Number:
- 0001140361-13-035242
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-06 16:15:25
- Reporting Period:
- 2010-04-14
- Filing Date:
- 2013-09-06
- Accepted Time:
- 2013-09-06 16:15:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1296391 | Tengion Inc | TNGN | Biological Products, (No Disgnostic Substances) (2836) | 200214813 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1352452 | Lorin Randall | C/O Tengion, Inc. 3929 Westpoint Blvd., Suite G Winston-Salem NC 27103 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-04-14 | 379 | $0.00 | 379 | No | 4 | C | Direct | |
Common Stock | Disposition | 2013-09-04 | 379 | $0.63 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series C Convertible Preferred Stock | Disposition | 2010-04-14 | 54,941 | $0.00 | 379 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct |
Footnotes
- On 6/14/12, the Company completed a one-for-ten reverse stock split. The common stock amounts in the filing relating to securities acquired prior to 6/14/12 have been adjusted to reflect the one-for-ten reverse stock split.
- These securities are Preferred Stock of the Issuer and do not have an expiration date. These securities automatically converted into common stock of the Issuer on a 14.5-for-one basis upon the closing of the Issuer's initial public offering of common stock.